Halozyme Therapeutics Inc (HALO)
63.02
+1.15
(+1.86%)
USD |
NASDAQ |
Apr 02, 16:00
61.25
-1.77
(-2.81%)
After-Hours: 20:00
Halozyme Therapeutics Profit Margin (Quarterly): 45.98% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 16.72% |
| Johnson & Johnson | 15.24% |
| Catalyst Pharmaceuticals Inc | 39.44% |
| Merck & Co Inc | 23.96% |
| Semler Scientific Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 162.4% |
| Return on Assets | 22.83% |
| Return on Invested Capital | 25.00% |
| Gross Profit Margin (Quarterly) | 85.89% |
| Operating Margin (Quarterly) | 58.89% |
| Return on Net Operating Assets | 33.56% |